Global challenges in liver disease
- PMID: 16941687
- DOI: 10.1002/hep.21347
Global challenges in liver disease
Abstract
Immigration, cheap air travel, and globalization are all factors contributing to a worldwide spread of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. End-stage chronic liver disease (ESLD) as a result of co-infection with HBV/HCV is now the major cause of death for individuals who have been infected with the HIV virus. The high incidence of HCV infection in Egypt--the legacy left from the mass use of tartar emetic to eradicate schistosomiasis, as in other high prevalence areas--will take years to reduce. Steatohepatitis due to non-alcoholic fatty liver disease is developing into a new and major health problem as a result of rising levels of obesity in populations worldwide. Hepatic steatosis also has an adverse influence on the progression of other liver diseases including chronic HCV infection and alcoholic liver disease. In many countries, considerable public concern is on the rise due to increased levels of alcohol consumption adversely affecting younger and affluent age groups. With the rising prevalence of cirrhosis, primary hepatocellular carcinoma (HCC) is increasing in frequency as is that of primary intrahepatic cholangiocarcinoma. Finally, despite the successes of liver transplantation, many deserving patients are not getting transplants due to low levels of cadaver organ donation in many countries, thereby increasing pressures on the use of living donor liver transplantation. Only through a concerted effort from governments, health agencies, healthcare professionals at all levels, and the pharmaceutical industry can this grim outlook for liver disease worldwide be reversed.
Similar articles
-
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5. Adv Parasitol. 2016. PMID: 27015949 Review.
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714 Review.
-
The global impact of hepatic fibrosis and end-stage liver disease.Clin Liver Dis. 2008 Nov;12(4):733-46, vii. doi: 10.1016/j.cld.2008.07.007. Clin Liver Dis. 2008. PMID: 18984463 Review.
-
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.J Hepatol. 2006 Oct;45(4):529-38. doi: 10.1016/j.jhep.2006.05.013. Epub 2006 Jun 23. J Hepatol. 2006. PMID: 16879891
-
Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.Clin Transpl. 2012:41-65. Clin Transpl. 2012. PMID: 23721009
Cited by
-
Targeted Proteomics for Monitoring One-Carbon Metabolism in Liver Diseases.Metabolites. 2022 Aug 24;12(9):779. doi: 10.3390/metabo12090779. Metabolites. 2022. PMID: 36144184 Free PMC article. Review.
-
Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia.Saudi Med J. 2016 Oct;37(10):1114-9. doi: 10.15537/smj.2016.10.14708. Saudi Med J. 2016. PMID: 27652363 Free PMC article.
-
Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.Hepatol Int. 2016 Jul;10(4):647-56. doi: 10.1007/s12072-016-9729-2. Epub 2016 Apr 13. Hepatol Int. 2016. PMID: 27074850
-
Retreatment with peginterferon and ribavirin in chronic hepatitis C.World J Gastroenterol. 2015 Feb 14;21(6):1994-9. doi: 10.3748/wjg.v21.i6.1994. World J Gastroenterol. 2015. PMID: 25684969 Free PMC article.
-
Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.Clin Vaccine Immunol. 2012 May;19(5):780-6. doi: 10.1128/CVI.00050-12. Epub 2012 Mar 21. Clin Vaccine Immunol. 2012. PMID: 22441392 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical